Mitsubishi UFJ Trust & Banking Corp
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1462160
TOKYO, M0
Position in ALNY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$28,190,254
+$4,110,530 QoQ
Shares Held
93,646
+28.7% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#112
of 784 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mitsubishi UFJ Trust & Banking Corp holds $324,055,173 across 66 Biotechnology names. ALNY ranks #5 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
174,812 | $86,834,364 | |
| 2 | RPRX |
Royalty Pharma plc
|
1,307,514 | $73,312,309 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,523 | $40,856,211 | |
| 4 | INCY |
Incyte Corp
|
312,130 | $35,383,056 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
93,646 | $28,190,254 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
65,240 | $12,218,147 | |
| 7 | INSM |
INSMED Inc
|
91,077 | $9,710,629 | |
| 8 | EXEL |
Exelixis, Inc.
|
170,171 | $9,259,004 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,190,254 | 93,646 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $24,079,724 | 72,777 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $31,572,217 | 79,397 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $35,322,216 | 77,461 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $27,957,000 | 85,734 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $29,881,763 | 110,665 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $27,457,382 | 116,686 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $33,094,909 | 120,332 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $65,230,920 | 268,440 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $46,606,280 | 311,852 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $66,825,058 | 349,120 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $68,479,611 | 386,672 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $74,730,183 | 393,441 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $81,717,337 | 407,934 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $109,360,587 | 460,175 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $95,005,543 | 474,648 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $69,143,983 | 474,076 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $76,493,525 | 468,452 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $79,874,043 | 471,011 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $91,921,770 | 486,848 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $84,533,180 | 498,662 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $73,714,025 | 522,091 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $70,553,172 | 542,842 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $80,567,613 | 553,349 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $84,365,528 | 569,614 | Shares | Sole | 2020-09-11 | |
| 2020-03-31 | $62,961,670 | 578,426 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||